hrp0097p2-232 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

Diabetes insipidus in pediatric onset langerhans cell histiocytosis with excellent response to treatment.

Rani Rai Versha , Awais Rimsha , Rathore Heeranand , Noor Ibrahim Mohsina , Riaz Maira

Introduction: Langerhans cell histiocytosis is a neoplastic disorder characterized by proliferation of myeloid dendritic cells. It can involve single system or multisystem with commonly involving sites including skin, bone, central nervous system, lung, hematopoietic system, liver and spleen. It also involves the endocrine system with diabetes insipidus a common presentation in 15-50% cases. It has a broad spectrum of presentation ranging from a relatively ben...

hrp0095p1-207 | Adrenals and HPA Axis | ESPE2022

Clinical and genetic characteristics of androgen insensitivity syndrome

Ting Wu

Background: Androgen insensitivity syndrome (AIS) is a common 46XY disorders of sex development (DSD), which is mainly caused by mutations in the androgen receptor (AR) gene. The clinical manifestations vary among patients, depending on residual androgen receptor activity.Methods: Five patients with different degrees of masculinization of external genitalia were selected as the research objects. As well as the detailed m...

hrp0092s3.3 | Novel Insights in Our Understanding of Disorders of Sex Development: From Genes to Clinical Outcomes | ESPE2019

Novel Insights into Sex Determination: Mutual Antagonism of Pro-Testis and Pro-Ovary Signalling Pathways

Greenfield Andy

There is no single conception of sex that covers the multitude of biological process that are commonly encompassed by the term and its cognates. Gonadal sex determination is sometimes known as 'primary' sex determination due to its centrality in our understanding of 'maleness' and 'femaleness'. In mammals, this is characterised by the sexually dimorphic development of an initially bipotential gonadal primordium in the fetus into either a testis or an ov...

hrp0092p3-24 | Adrenals and HPA Axis | ESPE2019

Clinical Characteristics and Genetic Analysis in one Patient with Congenital Lipoid Adrenal Hyperplasia

Xi Li , Chang Zhuo , Pei Zhou , Li Xiaojing , Luo Feihong

Objective: To explore the clinical and molecular genetic characteristics of congenital lipoid adrenal hyperplasia (CLAH), and to sequence the acute regulatory protein (steroid acute regulatory, StAR) gene of the infant patient and her pedigree.Methods: Physical examination, laboratory tests, and imaging examination of the 1-month- old patient with CLAH were collected. DNA was extracted from blood samples of the patient a...

hrp0092p3-143 | GH and IGFs | ESPE2019

The Convulsions Maze: Epilepsy Versus Hypoglycemia

fawzy Dina

Introduction: Diagnosing a seizure can be tricky. The first thing a doctor should do is to rule out other conditions, such as non-epileptic seizures. One of these conditions may be metabolic disturbance as hypoglycemia. Growth hormone deficiency is commonly presented with short stature during childhood .hypoglycemia is a rare presentation of the disease.Case report: a four year and seven months male child, diagnosed as a...

hrp0092p3-317 | Late Breaking Abstracts | ESPE2019

Body Mass Index and Incident Type 1 Diabetes in Children from Lesser Poland Over an 11 Year Observation Period

Wasyl-Nawrot Barbara , Wójcik Małgorzata , Nazim Joanna , Skupień Jan , Starzyk Jerzy

Background: One of the speculated causes of the decreasing age of onset of type 1 diabetes is the increase in body weight in children. This so-called accelerator hypothesis is, however, controversial. The aim of the study was to test whether younger age of type 1 diabetes onset is associated with higher BMI-SDS at the time of diagnosis.Methods: Retrospective data analysis from medical records of all patients und...

hrp0089mte4.1 | The Use of Modern Technologies to Optimize Diabetes Care | ESPE2018

The Use of Modern Technologies to Optimize Diabetes Care

Kordonouri Olga

The gold standard for the treatment of Type 1 diabetes in children and adolescents is the intensified insulin therapy using either multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) pump according to the basal-bolus-principle. Blood glucose measurement is the mainstay of diabetes management, guiding insulin dosing decisions and monitoring glycemic control. New technological advances including subcutaneous continuous glucose monitoring (CGM), eit...

hrp0089p3-p004 | Adrenals and HPA Axis P3 | ESPE2018

Basal Levels of 17-hydroxyprogesterone can Distinguish Isolated Precocious Pubarche from Non-Classical Congenital Adrenal Hyperplasia in Children: A Prospective Observational study

Grandone Anna , Festa Adalgisa , Mariani Michela , Luongo Caterina , Giudice Emanuele Miraglia del

Background: Basal levels of androgens, in particular 17-OHprogesterone (17OHP), are widely debated as predictors of non-classical congenital adrenal hyperplasia (NCCAH) among patients with precocious pubarche (PP). So many authors suggested the execution of ACTH stimulation test in all children with PP. The aim of our study was to identify clinical and biochemical predictors of NCCAH in children with PP.Methods: We conducted a prospective study of 92 pat...

hrp0089p2-p295 | Multisystem Endocrine Disorders P2 | ESPE2018

Paediatric Endocrinology Mapping and Services in Nigeria: A Decade After

Yarhere Iroro , Jaja Tamunopriye

Background: With the inception of the Paediatric endocrinology training centre for Africa and West Africa a decade ago, several endocrinologists have been trained and are practicing in various part of Africa and Nigeria. The services and challenges faced are articulated in this survey.Objective and hypothesis: To determine the service delivery and challenges faced by paediatric endocrinology units in Nigeria.Method: A self-administ...

hrp0086s6.1 | Prevention of childhood obesity | ESPE2016

Long-term Consequences of Childhood Obesity: The Impact of Genes and Lifestyle

Franks Paul

In most complex traits, susceptibility to certain risk exposures and response to clinical interventions in is under genetic control, a concept broadly termed “gene-environment interaction”. Although in animals and in plants there is evidence supporting this notion, in humans most evidence is confined to rare monogenic disorders. In complex diseases like type 2 diabetes and obesity, interactions between genetic and environmental risk factors are likely to begin very e...